Citadel Advisors’s Tecogen Inc TGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Buy
147,472
+98,552
+201% +$362K ﹤0.01% 9937
2025
Q4
$242K Sell
48,920
-164,788
-77% -$1.24M ﹤0.01% 10628
2025
Q3
$1.88M Buy
+213,708
New +$1.71M ﹤0.01% 6188
2019
Q4
Sell
-10,445
Closed -$25K 9894
2019
Q3
$25K Sell
10,445
-11,285
-52% -$33.7K ﹤0.01% 8892
2019
Q2
$81K Sell
21,730
-10,522
-33% -$38.8K ﹤0.01% 8596
2019
Q1
$129K Buy
+32,252
New +$124K ﹤0.01% 8453

Other funds holding TGEN

Citadel Advisors's TGEN Position: Q1 2026 in Review

Citadel Advisors increased its Tecogen Inc (TGEN) stake by 201% in Q1 2026, buying an estimated $362K and bringing the position to 147,472 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #9937.

Citadel Advisors first reported a position in TGEN in Q1 2019 and has held it in 6 quarters since. The position peaked at $1.88M in Q3 2025. 62 funds tracked by Wall St. Rank hold TGEN as of Q1 2026.

  • Citadel Advisors held 147,472 shares of Tecogen Inc worth $378K as of Q1 2026.
  • Citadel Advisors bought 98,552 Tecogen Inc shares in Q1 2026, an estimated $362K.
  • Tecogen Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9937 holding.
  • Citadel Advisors first reported a position in Tecogen Inc in Q1 2019 and has held it in 6 quarters since.
  • Citadel Advisors's Tecogen Inc position peaked at $1.88M in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Tecogen Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.